General
publicado em 27/05/2013 às 22h51:00
   Dê o seu voto:

ANVISA keeps selling slimming sibutramine based in Brazil

Patients and physicians must sign a liability waiver, presented along with the prescription at the time of purchase

 
font size
A-
A+

Some pieces of information on this page may have been automatically translated. Makernews is not responsible for the irregularities resulting from these translations. When in doubt,      consult the original text.



The slimming based sibutramine continue with the sale released in the country. The decision on Monday (27) is the executive board of the National Agency for Sanitary Surveillance (ANVISA). The regulatory agency monitored the drug over the past year.

In 2011, ANVISA decided to banish the slimming-based amfepramone femproporex and mazindol, called amphetamines. Already sibutramine remained released, but with restrictions. Patients and physicians must sign a liability waiver, presented along with the prescription at the time of purchase.

Resolution 52, 2011, ANVISA, determined that health professionals, companies holding registration and pharmacies must notify compulsorily the National Health Surveillance in cases of adverse effects associated with the use of drugs with sibutramine.

In March, the CEO of ANVISA, Dirceu Barbano, declared that there was no reason to ban the sale of the substance, since studies done by the agency indicated no increase in the use of sibutramine, even with the prohibition of other diet pills.

Source: AGÊNCIA BRASIL
  • Share this pageShare this page
  • Share this pageCorrect
  • ShareShare
  • AlertAlert
Reduced link: 
  • You are recommending this story: ANVISA keeps selling slimming sibutramine based in Brazil
  • Fill in the following form to send your recommendation to your friend:

  • You are suggesting a correction for this story: ANVISA keeps selling slimming sibutramine based in Brazil


Receba notícias do iSaúde no seu e-mail de acordo com os assuntos de seu interesse.
Seu nome:
Seu email:
Desejo receber um alerta com estes assuntos:
sibutramine    National Health Surveillance Agency    ANVISA    amfepramone femproporex    mazindol    amphetamine    National Sanitary Surveillance System    Dirceu Barbano   
Comments:
Comment
Leave your comment
Close
(Required fields are marked with an *)

(Your email address will never be published or shared.)

Enter the letters and numbers below and click in the button "send"

  • Twitter iSaúde
advertising
Informe Saúde printed version

Recommend the portal
Close [X]
  • You are recommending this story: http://www.isaude.net
  • Fill in the following form to send your recommendation to your friend:

RSS news from the portal  iSaúde.net
Get the newsletter of the portal  iSaúde.net
Recommend the portal iSaúde.net
News from  iSaúde.net in your blog or website.
Get news on the subject of your interest.
© 2000-2011 www.isaude.net Todos os direitos reservados.